NO3087076T3 - - Google Patents

Info

Publication number
NO3087076T3
NO3087076T3 NO14808506A NO14808506A NO3087076T3 NO 3087076 T3 NO3087076 T3 NO 3087076T3 NO 14808506 A NO14808506 A NO 14808506A NO 14808506 A NO14808506 A NO 14808506A NO 3087076 T3 NO3087076 T3 NO 3087076T3
Authority
NO
Norway
Application number
NO14808506A
Other languages
Norwegian (no)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NO3087076T3 publication Critical patent/NO3087076T3/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/06Peri-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/527Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim spiro-condensed
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Lubricants (AREA)
  • Developing Agents For Electrophotography (AREA)
NO14808506A 2013-12-23 2014-12-03 NO3087076T3 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP13006052 2013-12-23
PCT/EP2014/003226 WO2015096884A1 (fr) 2013-12-23 2014-12-03 Dérivés d'imidazopyrazinone
EP14808506.1A EP3087076B1 (fr) 2013-12-23 2014-12-03 Dérivés d'imidazopyrazinone

Publications (1)

Publication Number Publication Date
NO3087076T3 true NO3087076T3 (fr) 2018-02-24

Family

ID=49916790

Family Applications (1)

Application Number Title Priority Date Filing Date
NO14808506A NO3087076T3 (fr) 2013-12-23 2014-12-03

Country Status (23)

Country Link
US (1) US9718826B2 (fr)
EP (1) EP3087076B1 (fr)
JP (1) JP6446461B2 (fr)
KR (1) KR20160101188A (fr)
CN (1) CN105829317B (fr)
AU (1) AU2014372896B2 (fr)
CA (1) CA2934663A1 (fr)
DK (1) DK3087076T3 (fr)
ES (1) ES2654403T3 (fr)
HR (1) HRP20171783T1 (fr)
HU (1) HUE037606T2 (fr)
IL (1) IL246406A0 (fr)
LT (1) LT3087076T (fr)
MX (1) MX364859B (fr)
NO (1) NO3087076T3 (fr)
PL (1) PL3087076T3 (fr)
PT (1) PT3087076T (fr)
RS (1) RS56746B1 (fr)
RU (1) RU2672885C2 (fr)
SG (1) SG11201605189YA (fr)
SI (1) SI3087076T1 (fr)
TW (1) TWI637956B (fr)
WO (1) WO2015096884A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017156350A1 (fr) 2016-03-09 2017-09-14 K-Gen, Inc. Méthodes de traitement du cancer
TWI808055B (zh) 2016-05-11 2023-07-11 美商滬亞生物國際有限公司 Hdac 抑制劑與 pd-1 抑制劑之組合治療
TWI794171B (zh) 2016-05-11 2023-03-01 美商滬亞生物國際有限公司 Hdac抑制劑與pd-l1抑制劑之組合治療
TW201822637A (zh) 2016-11-07 2018-07-01 德商拜耳廠股份有限公司 用於控制動物害蟲的經取代磺醯胺類
CN108403697A (zh) * 2018-05-02 2018-08-17 吉林大学 吡嗪酮类小分子抑制剂在制备抗肿瘤药物中的应用
CA3111878A1 (fr) * 2018-09-07 2020-03-12 Merck Patent Gmbh Derives de 5-morpholin-4-yl-pyrazolo[4,3-b]pyridine
JP7433403B1 (ja) 2022-12-06 2024-02-19 本田技研工業株式会社 内燃機関及び鞍乗型車両

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005089352A (ja) * 2003-09-16 2005-04-07 Kissei Pharmaceut Co Ltd 新規なイミダゾ[1,5−a]ピラジン誘導体、それを含有する医薬組成物およびそれらの用途
CN101468988A (zh) * 2007-12-26 2009-07-01 上海恒瑞医药有限公司 哌嗪类衍生物,其制备方法及其在医药上的应用
ES2627703T3 (es) 2010-01-22 2017-07-31 Fundación Centro Nacional De Investigaciones Oncológicas Carlos Iii Inhibidores de PI3·quinasa
UA112795C2 (uk) * 2012-03-28 2016-10-25 Мерк Патент Гмбх Біциклічні піразинонові похідні
PT2844659T (pt) * 2012-05-04 2016-08-31 Merck Patent Gmbh Derivados de pirrolotriazinona

Also Published As

Publication number Publication date
AU2014372896B2 (en) 2018-08-16
RU2016130148A (ru) 2018-01-30
LT3087076T (lt) 2017-12-27
CN105829317B (zh) 2019-03-29
CN105829317A (zh) 2016-08-03
US9718826B2 (en) 2017-08-01
JP2017500353A (ja) 2017-01-05
ES2654403T3 (es) 2018-02-13
HUE037606T2 (hu) 2018-09-28
JP6446461B2 (ja) 2018-12-26
CA2934663A1 (fr) 2015-07-02
DK3087076T3 (da) 2017-11-13
IL246406A0 (en) 2016-08-31
MX2016008042A (es) 2016-09-16
RU2672885C2 (ru) 2018-11-20
EP3087076B1 (fr) 2017-09-27
RU2016130148A3 (fr) 2018-07-25
AU2014372896A1 (en) 2016-08-04
EP3087076A1 (fr) 2016-11-02
US20170002010A1 (en) 2017-01-05
SI3087076T1 (en) 2018-01-31
PT3087076T (pt) 2018-01-03
RS56746B1 (sr) 2018-03-30
PL3087076T3 (pl) 2018-01-31
TWI637956B (zh) 2018-10-11
WO2015096884A1 (fr) 2015-07-02
TW201605862A (zh) 2016-02-16
SG11201605189YA (en) 2016-07-28
KR20160101188A (ko) 2016-08-24
MX364859B (es) 2019-05-09
HRP20171783T1 (hr) 2017-12-29

Similar Documents

Publication Publication Date Title
BR112016012378A2 (fr)
BR112016002981A2 (fr)
BR112014018502A2 (fr)
BR112014019326A2 (fr)
BR112014018516A2 (fr)
BR112014020341A2 (fr)
BR112014018480A2 (fr)
BR112014017855A2 (fr)
BR112015020765A2 (fr)
BR112014021878A2 (fr)
BR112014018468A2 (fr)
BR112014018207A2 (fr)
BR112014019204A2 (fr)
BR112015015948A2 (fr)
BR112014018578A2 (fr)
BR112014018483A2 (fr)
BR112015015312A2 (fr)
BR112016014141A2 (fr)
BR112014018353A2 (fr)
RU2016130148A3 (fr)
BR112014018496A2 (fr)
BR112014018514A2 (fr)
BR112014017992A2 (fr)
BR112014019241A2 (fr)
BR112014020767A2 (fr)